Orbital and Eyelid B-Cell Lymphoma: A Multicenter Retrospective Study by Gustavo Savino, Giulia Midena, Maria Antonietta Blasi, Remo Battendieri, Gabriela Grimaldi, Martina Maceroni, Fausto Tranfa, Pasquale Napolitano, Vittoria Lanni, Adriana Iuliano

“…Results: Extranodal marginal zone B-cell lymphoma was the most frequent subtype (66%), followed by small lymphocytic lymphoma (12.7%), diffuse large B-cell lymphoma (DLBCL) (9.2%), follicular lymphoma (6.6%), mantle cell lymphoma (4.3%) and Burkitt lymphoma (1.2%). The probability of relapse was influenced by the histopathologic subtype DLBCL (OR = 7.7, 95% CI 1.8–32.3) and treatment with chemotherapy (OR = 14.9, 95% CI 2.6–83.7). …”
Get full text

Impact of Epstein-Barr virus co-infection on natural acquired Plasmodium vivax antibody response. by Michelle H F Dias, Luiz F F Guimarães, Matheus G Barcelos, Eduardo U M Moreira, Maria F A do Nascimento, Taís N de Souza, Camilla V Pires, Talita A F Monteiro, Jaap M Middeldorp, Irene S Soares, Cor J F Fontes, Francis B Ntumngia, John H Adams, Flora S Kano, Luzia H Carvalho

“…<h4>Background</h4>The simultaneous infection of Plasmodium falciparum and Epstein-Barr virus (EBV) could promote the development of the aggressive endemic Burkitt's Lymphoma (eBL) in children living in P. falciparum holoendemic areas. …”
Get full text

Discovery of Selective SIRT2 Inhibitors as Therapeutic Agents in B-Cell Lymphoma and Other Malignancies by Sarwat Chowdhury, Smitha Sripathy, Alyssa A. Webster, Angela Park, Uyen Lao, Joanne H. Hsu, Taylor Loe, Antonio Bedalov, Julian A. Simon

“…Previously, we described the discovery of a dual SIRT1/SIRT2 inhibitor called cambinol (IC₅₀ 56 and 59 &#181;M, respectively), which showed cytotoxic activity against cancer cells in vitro and a marked anti-proliferative effect in a Burkitt lymphoma mouse xenograft model. A number of recent studies have shown a protective effect of SIRT1 and SIRT3 in neurodegenerative and metabolic diseases as well as in certain cancers prompting us to initiate a medicinal chemistry effort to develop cambinol-based SIRT2-specific inhibitors devoid of SIRT1 or SIRT3 modulating activity. …”
Get full text

Antibodies against six human herpesviruses in relation to seven cancers in black South Africans by de González, A, Urban, M, Sitas, F, Blackburn, N, Hale, M, Patel, M, Ruff, P, Sur, R, Newton, R, Beral, V

“…For example, Epstein-Barr Virus is considered a cause of Burkitt's lymphoma and other immunosuppression related lymphomas, Hodgkin lymphoma, and nasopharyngeal cancer. …”

Phenotypic spectrum in a family with a novel RAC2 p.I21S dominant‐activating mutation by Louisa Ashby, Lydia Chan, Christine Winterbourn, See‐Tarn Woon, Paula Keating, Raoul Heller, Rohan Ameratunga, Ignatius Chua, Kuang‐Chih Hsiao

“…P1's maternal cousin (P7) presented with Burkitt's lymphoma at age 9. All affected individuals are alive and none has required HSCT to date. …”
Get full text

Benefit of continuous kidney replacement therapy for managing tumor lysis syndrome in children with hematologic malignancies by Ashlea Anderson, Laurie Shoulders, Vinson James, Emily Ashcraft, Cheng Cheng, Raul Ribeiro, Lama Elbahlawan

“…T-cell acute lymphoblastic leukemia was the most common diagnosis (n=10), followed by acute myeloid leukemia (n=4), Burkitt lymphoma (n=4), and B-cell acute lymphoblastic leukemia (n=2). …”
Get full text

Endoscopic features of colorectal lymphoma according to histological type by Tatsuo Yachida, Takahisa Matsuda, Taku Sakamoto, Takeshi Nakajima, Yasuo Kakugawa, Akiko Miyagi Maeshima, Hirokazu Taniguchi, Ryoji Kushima, Kensei Tobinai, Hideki Kobara, Hisashi Masugata, Tsutomu Masaki, Yutaka Saito

“…Moreover, the most common histological subtypes were diffuse large B‐cell lymphoma (DLBCL) in 39 patients (43%) and mantle cell lymphoma (MCL) in 23 patients (26%), followed by follicular lymphoma (FL; 17%), mucosa‐associated lymphoid tissue (MALT) lymphoma (9%), peripheral T‐cell lymphoma‐NOS (2%), monomorphic epitheliotropic intestinal T‐cell lymphoma (MEITL; 2%), and Burkitt lymphoma (1%). More than half of the DLBCL (52%), MCL (52%), and MALT (56%) lymphomas were macroscopically classified as polypoid types. …”
Get full text

An unusual cause of adrenal insufficiency with elevation of 17-hydroxyprogesterone: case report by Claudia Teti, Giampaolo Bezante, Federico Gatto, Keyvan Khorrami Chokami, Manuela Albertelli, Marco Falchi, Giulio Bovio, Sandro Teresio Nati, Diego Ferone, Mara Boschetti

“…The histology revealed a high grade non-Hodgkin lymphoma with an immunophenotype consistent with intermediate aspects between diffuse large B-cell and Burkitt lymphoma, with a high proliferation index (KI-67 > 90%). …”
Get full text

Primary thyroid lymphoma: A single-center experience by Jin Seok Lee, Su-Jin Shin, Hyeok Jun Yun, Seok Mo Kim, Hojin Chang, Yong Sang Lee, Hang-Seok Chang

“…Histological analyses revealed that all 10 lymphomas were non-Hodgkin B-cell lymphoma; six patients had diffuse large B-cell lymphoma, three had mucosa-associated lymphoid tissue lymphoma, and one had Burkitt lymphoma. Four patients received chemotherapy, two were treated with chemoradiation therapy, one received radiation therapy only, one did not require more treatment after surgery, one refused treatment, and one was transferred to another hospital.ConclusionsAlthough PTLs are scarce, clinicians should be aware of this rare entity and evaluate and treat PTLs on an individual basis.…”
Get full text

Clinical and Pathological Features of Double-Hit and Triple-Hit High-Grade B-Cell Lymphomas: A Retrospective Study from Three Portuguese Tertiary Centers by Rui Almeida, Carlos Abrantes, Davide Gigliano, Rui Caetano Oliveira, Paulo Teixeira, Marta Viegas, Ângelo Rodrigues, Maria José Julião

“…Morphologic features of  DLBCL were present in 50% of cases, morphological features of both DLBCL and Burkitt lymphoma (DLBCL/BL) in 45.8% and 4.2% of blastoid morphology. …”
Get full text

The Role of the MYC/miR-150/MYB/ZDHHC11 Network in Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma by Lotteke J. Y. M. Ziel-Swier, Yichen Liu, Annika Seitz, Debora de Jong, Jasper Koerts, Bea Rutgers, Rianne Veenstra, Fazlyn R. Abdul Razak, Agnieszka Dzikiewicz-Krawczyk, Anke van den Berg, Joost Kluiver

“…We previously described involvement of the MYC/miR-150/MYB/ZDHHC11 network in the growth of Burkitt lymphoma (BL) cells. Here we studied the relevance of this network in the two other B-cell lymphomas: Hodgkin lymphoma (HL) and diffuse large B-cell lymphoma (DLBCL). …”
Get full text

Circulating microRNAs in Cerebrospinal Fluid and Plasma: Sensitive Tool for Detection of Secondary CNS Involvement, Monitoring of Therapy and Prediction of CNS Relapse in Aggressiv... by Pavle Krsmanovic, Heidi Mocikova, Kamila Chramostova, Magdalena Klanova, Marie Trnkova, Michal Pesta, Peter Laslo, Robert Pytlik, Tomas Stopka, Marek Trneny, Vit Pospisil

“…We identified a set of five oncogenic microRNAs (miR-19a, miR-20a, miR-21, miR-92a, and miR-155) in CSF that detect, with high sensitivity, secondary CNS lymphoma involvement in aggressive B-NHL, including DLBCL, MCL, and Burkitt lymphoma. Their combination into an oncomiR index enables the separation of CNS lymphomas from systemic lymphomas or nonmalignant controls with high sensitivity and specificity, and high Receiver Operating Characteristics (DLBCL AUC = 0.96, MCL = 0.93, BL = 1.0). …”
Get full text

Clinical Interest of LMO2 Testing for the Diagnosis of Aggressive Large B-Cell Lymphomas by Ivonne Vazquez, Natalia Papaleo, Eugenia Garcia, Marta Salido, Antonio Salar, Silvia Hernandez, Xavier Calvo, Luis Colomo

“…A series of 365 samples obtained from 351 patients, including 28 Burkitt lymphoma, 230 diffuse large B-cell lymphoma, 30 high-grade B-cell lymphoma with <i>MYC</i> and <i>BCL2/BCL6</i> rearrangements, eight high-grade B-cell lymphoma-NOS, 43 transformed diffuse large B-cell lymphoma, and 26 high-grade follicular lymphomas was analyzed. …”
Get full text

Epstein–Barr Virus and the Pathogenesis of Diffuse Large B-Cell Lymphoma by Aisling M. Ross, Ciara I. Leahy, Fiona Neylon, Jana Steigerova, Patrik Flodr, Martina Navratilova, Helena Urbankova, Katerina Vrzalikova, Lucia Mundo, Stefano Lazzi, Lorenzo Leoncini, Matthew Pugh, Paul G. Murray

“…Epstein–Barr virus (EBV), defined as a group I carcinogen by the World Health Organization (WHO), is present in the tumour cells of patients with different forms of B-cell lymphoma, including Burkitt lymphoma, Hodgkin lymphoma, post-transplant lymphoproliferative disorders, and, most recently, diffuse large B-cell lymphoma (DLBCL). …”
Get full text

Rational drug combinations design against intratumoral heterogeneity and clonal evolution by Zhao, Boyang

Get full text

Antibodies against six human herpesviruses in relation to seven cancers in black South Africans: a case control study. by Berrington de González, A, Urban, M, Sitas, F, Blackburn, N, Hale, M, Patel, M, Ruff, P, Sur, R, Newton, R, Beral, V

“…For example, Epstein-Barr Virus is considered a cause of Burkitt's lymphoma and other immunosuppression related lymphomas, Hodgkin lymphoma, and nasopharyngeal cancer. …”

The Prognosis of Adult Burkitt's Cell Leukemia in Real-Life Clinical Practice by Ümit Yavuz Malkan, Gürsel Güneş, Hakan Göker, İbrahim C. Haznedaroğlu, Kadir Acar, Eylem Eliaçık, Sezgin Etgül, Tuncay Aslan, Seda Balaban, Haluk Demiroğlu, Osman İ. Özcebe, Nilgün Sayınalp, Salih Aksu, Yahya Büyükaşık

“…Objective: Many studies reported an improved prognosis in patients with Burkitt's lymphoma obviating the need of stem cell transplantation. …”
Get full text

Maternal autoimmune disease and its association with childhood cancer: A population-based case-control study in Denmark by Helen T. Orimoloye, Nicholas Nguyen, Chuanjie Deng, Chai Saechao, Beate Ritz, Jorn Olsen, Johnni Hansen, Julia E. Heck

“…Results: Autoimmune diseases (all types) were positively associated with all childhood cancers combined (Odds Ratio (OR) = 1.25, 95% CI 1.06, 1.47), acute lymphoblastic leukemia (OR =1.52, 95% CI 1.09, 2.13), Burkitt lymphoma (OR = 2.69, 95% CI 1.04, 6.97), and central nervous system tumors (OR = 1.45, 95% CI 1.06, 1.99), especially astrocytoma (OR = 2.27, 95% CI 1.36, 3.77) and glioma (OR = 1.75, 95% CI 1.13, 2.73). …”
Get full text

Ultrasonographic Analysis of Primary Thyroid Lymphoma by Xiangliu OUYANG, Bei GAO, Yanbin WANG, Liyun LIU, Cheng GU, Lichun ZHENG

“…Results Pathological results of PTL group: 10 cases were diffuse large B-cell lymphoma, 4 cases were mucous-associated lymphoid tissue extranodular marginal zone B-cell lymphoma, 1 case was follicular lymphoma, and 1 case was Burkitt lymphoma. Pathological results of thyroid cancer group: 11 cases were papillary carcinoma, 4 cases were follicular carcinoma and 1 case was medullary carcinoma. …”
Get full text

Combined chemoimmunotherapy of patients with mature B-cell non-Hodgkin lymphomas age group until 18 years: results of multicenter study NHL 2004 m with rituximab and modified B-NHL... by E. V. Samochatova, L. N. Schelikhova, M. B. Belogurova, A. V. Schamardina, E. V. Bascharova, D. V. Litvinov, N. V. Myakova, L. G. Fechina, O. P. Chlebnikova, E. V. Inuschkina, O. V. Riskal, P. Z. Schammasov, I. M. Yunusova, S. Yu. Umnova, D. M. Konovalov, A. G. Talalaev, J. V. Roumiantseva, A. A. Maschan

“…There was no case of remission death; relapse has developed only at one patient (neuroleukemia in patient with Burkitt lymphoma). 54 patients (88%) are in continuous complete remission. …”
Get full text